Page last updated: 2024-08-21

paeonol and Urinary Bladder Neoplasms

paeonol has been researched along with Urinary Bladder Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cai, LJ; Dong, Y; Han, CH; Li, BB; Li, R; Pang, K; Zhang, JJ; Zhang, ZG	1

Other Studies

1 other study(ies) available for paeonol and Urinary Bladder Neoplasms

Article	Year
Paeonol inhibits proliferation and induces cell apoptosis of human T24 and 5637 bladder cancer cells in vitro and in vivo. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2021, Volume: 23, Issue:3 Topics: Acetophenones; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Cell Proliferation; Flow Cytometry; Humans; In Situ Nick-End Labeling; In Vitro Techniques; Ki-67 Antigen; Mice; Mice, Nude; Neoplasm Transplantation; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays	2021

Article

Year

Paeonol inhibits proliferation and induces cell apoptosis of human T24 and 5637 bladder cancer cells in vitro and in vivo.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2021, Volume: 23, Issue:3

Topics: Acetophenones; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Cell Proliferation; Flow Cytometry; Humans; In Situ Nick-End Labeling; In Vitro Techniques; Ki-67 Antigen; Mice; Mice, Nude; Neoplasm Transplantation; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays

2021